GE HealthCare reported $21.3B of revenue over the trailing twelve months, +6.5% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $21.3B (to Q2 2026). Net income: $1.99B, trailing twelve months to Q2 2026. Operating margin: 13%, trailing twelve months to Q2 2026. EPS: $4.36, trailing twelve months to Q2 2026.

GEHCGE HealthCare

Healthcare

$71.45-2.5% 1Y

$71.45

$59.4952 weeks$88.08

GEHC as reported

GE HealthCare reported $21.3B of revenue over the trailing twelve months, +6.5% on the year before. 11 reported series are charted on this page, each one as filed.

$21.3B

Revenue, trailing twelve months · to Q2 2026 · +6.5% against the twelve months before

Net income: $1.99B
Net income · −11% year on year · trailing twelve months to Q2 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q2 2026
EPS: $4.36
EPS · −11% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for GEHC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$21.3B	+6.5%	Q2 2026
Net income	$1.99B	−11%	Q2 2026
EPS	$4.36	−11%	Q2 2026
Gross margin	40%	n/a	Q2 2026
Operating margin	13%	n/a	Q2 2026
Net margin	9.3%	n/a	Q2 2026
ROE	20%	n/a	Q2 2026
ROA	5.6%	n/a	Q2 2026
ROIC	12%	n/a	Q2 2026
Free cash flow	$1.62B	n/a	Q2 2024 · 8 quarters behind
P/E	16.4	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.